Roles of SAM and DDHD domains in mammalian intracellular phospholipase A1 KIAA0725p  by Inoue, Hiroki et al.
Biochimica et Biophysica Acta 1823 (2012) 930–939
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrRoles of SAM and DDHD domains in mammalian intracellular phospholipase
A1 KIAA0725p☆
Hiroki Inoue 1, Takashi Baba 1, Seiichi Sato, Ryuya Ohtsuki, Aya Takemori, Takuya Watanabe,
Mitsuo Tagaya, Katsuko Tani ⁎
School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, JapanAbbreviations: DOPA, 1,2-dioleoyl-sn-phosphatidic ac
ERGIC, endoplasmic reticulum-Golgi intermediate com
transferase; iPLA1, intracellular phospholipase A1; LPA,
LUV, large unilamellar vesicles; PA, phosphatidic acid; PC,
phatidylethanolamine; PH, pleckstrin homology; PI
phosphate; PI(4)P, phosphatidylinositol 4-phosphate;
4,5-bisphosphate; PI(5)P, phosphatidylinositol 5-phosp
PIP, phosphatidylinositol phosphate; PLA1, phospholipa
SAM, sterile alpha-motif; TLC, thin-layer chromatography
☆ This work was supported in part by Grants-in-Aid fo
to H.I. and 20570190 to K.T. from the Ministry of Educ
and Technology of Japan.
⁎ Corresponding author at: School of Life Sciences,
and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 1
42 676 6905.
E-mail address: tani@toyaku.ac.jp (K. Tani).
1 These authors contributed equally to this work.
0167-4889/$ – see front matter © 2012 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2012.02.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 27 December 2011
Received in revised form 31 January 2012
Accepted 1 February 2012







DDHD domainMembers of the intracellular phospholipase A1 family of proteins have been implicated in organelle
biogenesis and membrane trafﬁcking. The mammalian family comprises three members: phosphatidic
acid-preferring phospholipase A1 (PA-PLA1)/DDHD1, p125/Sec23ip and KIAA0725p/DDHD2, all of which
have a DDHD domain. PA-PLA1 is mostly cytosolic, while KIAA0725p and p125 are more stably associated
with the Golgi/endoplasmic reticulum (ER)-Golgi intermediate compartment (ERGIC) and ER exit sites, re-
spectively. Here we show that KIAA0725p and p125 are novel phosphoinositide-binding proteins. Deletion
and mutational analyses of KIAA0725p suggested that a sterile alpha-motif (SAM), which is also present in
p125, but not in cytosolic PA-PLA1, and the following DDHD domain comprise a minimal region for phos-
phatidylinositol 4-phosphate (PI(4)P)-binding. A construct with mutations in the positively charged cluster
of the SAM domain is defective in both phosphoinositide-binding and Golgi/ERGIC targeting. Consistent
with the view that the PI(4)P-binding is important for the membrane association of KIAA0725p, expression
of phosphoinositide phosphatase Sac1 reduces the association of expressed KIAA0725p with membranes. In
addition, we show that deletion of the DDHD domain or introduction of point mutations at the conserved
aspartate or histidine residues in the domain abolishes the phospholipase activity of KIAA0725p and
PA-PLA1. Together, our results suggest that KIAA0725p is targeted to speciﬁc organelle membranes in a
phosphoinositide-dependent manner, and that its SAM and DDHD domains are essential for its
phosphoinositide-binding and phospholipase activity.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Phosphoinositides including phosphatidylinositol 4-phosphate
(PI(4)P) play pivotal roles in membrane trafﬁcking [1,2]. Each phos-
phoinositide is abundant in speciﬁc organelle membranes; PI(4)P,
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tus, endosomes and the plasma membrane, respectively. Phosphoino-
sitides exert their effects by recruiting effector proteins that have
phosphoinositide-binding domains, such as the pleckstrin homology
(PH) domain and epsin N-terminal homology domain.
The intracellular phospholipase A1 (iPLA1) family is a recently
identiﬁed phospholipase family and has been implicated in organelle
biogenesis and membrane trafﬁcking. While most eukaryote families
only comprise one species, the mammalian family comprises three
members, phosphatidic acid (PA)-preferring phospholipase A1 (PA-
PLA1)/DDHD1/iPLA1α, p125/Sec23-interacting protein (Sec23ip)/
iPLA1β, and KIAA0725p/DDHD2/iPLA1γ. PA-PLA1 was puriﬁed as a
PA-preferring iPLA1 highly expressed in mature bovine testis [3–5].
p125 was identiﬁed as a protein that interacts with mammalian
Sec23 [6,7], which is one of the coat protein complex II components
involved in protein export from the endoplasmic reticulum (ER) [8].
p125 is localized in ER exit sites and plays a role in maintaining
their integrity in HeLa cells [9,10]. Our recent study demonstrated
that p125 ablation causes male subfertility in mice [11]. In contrast
to the robust PLA1 activity of PA-PLA1, PLA1 activity has not been
detected for p125 so far [12]. KIAA0725p was found through a
database search as a protein that is more homologous to p125 than
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phospholipids. KIAA0725p is localized in the cis-Golgi and perhaps
the ER-Golgi intermediate compartment (ERGIC) [12–14], and its
overexpression causes dissociation of coat and tethering proteins
from the Golgi as well as the aggregation of ER membranes. RNA in-
terference experiments have shown that KIAA0725p functions in
the transport of cholera toxin B from the Golgi to the ER [13], and of
vesicular stomatitis virus G protein from the Golgi to the plasma
membrane [14], although its participation in the former transport
process has not been conﬁrmed [14].
In this study, we examined the mechanism underlying the associ-
ation of KIAA0725p with membranes. Despite the absence of typical
phosphoinositide-binding domains, KIAA0725p was found to bind
to phosphatidylinositol phosphate (PIP). We show that a tandem
SAM-DDHD domain, which is located in the C-terminal region of
KIAA0725p, is responsible for this PIP binding. In addition, we
revealed the role of the DDHD domain, which is commonly present
in iPLA1 family proteins and some phosphatidylinositol transfer
proteins [15–17].
2. Experimental procedures
2.1. Plasmids and mutagenesis
The mammalian expression vector for FLAG-tagged human
KIAA0725p (pFLAG-CMV-KIAA0725p) was described previously
[12]. The open reading frame of KIAA0725p was ampliﬁed by PCR
from pFLAG-CMV-KIAA0725p and inserted into pEBG [18] and a ver-
sion of pFastBac (Invitrogen, Carlsbad, CA) modiﬁed by inserting the
coding sequence for glutathione-S-transferase (GST), resulting in ex-
pression constructs for an N-terminal GST-fusion form of KIAA0725p
in mammalian cells and Sf9 insect cells, respectively. Deletion and
point mutants of KIAA0725p or PA-PLA1 were constructed by stan-
dard PCR-based methods and inverse PCR [19], respectively, using
corresponding primer sets (Supplemental Table S1). The sequences
of all PCR-ampliﬁed open reading frames in the constructs were
conﬁrmed using an automated ABI DNA sequencer. Sac1 expression
constructs were kindly donated by Dr. P. Mayinger.
2.2. Antibodies
A polyclonal antibody against KIAA0725p was raised in rabbits
against bacterially expressed, puriﬁed GST-tagged KIAA0725p
(amino acids 1–120), and afﬁnity-puriﬁed by using a protein
comprising the same region of KIAA0725p but tagged with maltose-
binding protein instead of GST. A mouse monoclonal antibody against
ERGIC-53 was generously provided by Dr. H. P. Hauri. Rabbit
polyclonal (F7425) and mouse monoclonal (clone M2, F1804) anti-
bodies against a FLAG tag were purchased from Sigma-Aldrich (St.
Louis, MO). Rabbit polyclonal anti-GST (sc-459) and mouse monoclo-
nal anti-GM130 (clone 35, 610822) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA) and BD Biosciences (Franklin Lakes,
NJ), respectively. Horseradish peroxidase- or tetramethylrhodamine
isothiocyanate-conjugated goat secondary antibodies against rabbit
or mouse IgGs were obtained from Jackson ImmunoResearch (West
Grove, PA). An Alexa Fluor 488-conjugated goat secondary antibody
was purchased from Invitrogen.
2.3. Cell culture and transfection
HeLa and 293T cells were maintained in Eagle's minimum essen-
tial medium (α modiﬁcation) (Sigma-Aldrich) and Dulbecco's modi-
ﬁed Eagle's medium (Invitrogen), respectively, supplemented with
10% fetal bovine serum, penicillin (100 U/ml), and streptomycin
(100 μg/ml) at 37 °C with 5% CO2. Cells were plated 1 day before
transfection with plasmids using Lipofectamine 2000 (Invitrogen)according to the manufacturer's instructions. Cells were used for
assays 18 hours after transfection.2.4. Immunoﬂuorescence and microscopy
Cells were ﬁxed with PBS containing 4% paraformaldehyde and
165 mM glucose, and PBS containing 2% bovine serum albumin and
0.04% NaN3 was used for blocking and antibody dilution. Confocal
microscopy was performed using an Olympus Fluoview 1000 laser-
scanning confocal microscope with a 60×, 1.35-numerical-aperture
UPlanSApo oil immersion lens (Tokyo, Japan).2.5. Expression of GST fusion proteins in Sf9 cells and puriﬁcation
Expression of GST-tagged proteins in Sf9 cells and their puriﬁcation
were carried out according to themanufacturer's instructions for a Bac-
to-Bac baculovirus expression system (Invitrogen) and Glutathione
Sepharose 4B (GE Healthcare, Piscataway, NJ).2.6. Lipid overlay assay
PIP-strips membranes were purchased from Echelon Bioscience
(Salt Lake City, UT). Self-made PI(4)P/phosphatidylcholine (PC)
membranes were prepared as follows. PI(4)P (Echelon; diC16) and
PC (Avanti Polar Lipids, Alabaster, AL; 1,2-stearoyl-PC) were serially
diluted with CHCl3/methanol/50 mM HCl (5:10:4), and then spotted
onto Hybond-C extra nitrocellulose membranes (GE Healthcare) at
between 25 and 200 pmol/spot. The membranes were immersed in
Tris-buffered saline plus 0.1% Tween 20 containing 3% fatty acid free-
bovine serum albumin (Sigma-Aldrich) for 1 h and then incubated
with 0.5 pmol/ml puriﬁed GST fusion proteins in the buffer overnight
at 4 °C. Alternatively, 100,000g supernatants of cell lysates of 293T
cells transiently expressing the GST fusion proteins were used instead
of the puriﬁed proteins. After extensive washing, proteins bound to
lipids on the membranes were detected with an anti-GST antibody
and an ECL immunodetection system (GE Healthcare).2.7. Liposome sedimentation assay
All lipids were purchased from Avanti Polar Lipids. Liposomes
(large unilamellar vesicles (LUV)) were prepared as described previ-
ously [20] with slight modiﬁcations. Brieﬂy, for phosphatidylinositol
(PI)-containing LUVs, a mixture of 40% PC (chicken egg), 25% phos-
phatidylethanolamine (PE) (bovine liver), 15% phosphatidylserine
(PS) (porcine brain), 10% PI (porcine brain), and 10% cholesterol
was dried under a nitrogen gas ﬂow, rehydrated with reconstitution
buffer (200 mM sucrose, 20 mM Hepes, pH7.4, 20 mM KCl) to give
5 mM total lipids, vortexed, and then subjected to ﬁve freeze-thaw cy-
cles in liquid nitrogen andwater at room temperature. The lipid suspen-
sion was ﬁnally passed through an extruder equipped with 0.1 μmpore
ﬁlter (Avanti Polar Lipids) 11 times to prepare uniformly-sized LUVs.
For PI(4)P- or PI(4,5)P2-containing LUVs, 10% PI was replaced by 5% PI
and 5% PI(4)P or 5% PI(4,5)P2. 1 μM puriﬁed GST fusion proteins were
incubated with 1 mM of the prepared LUVs in PBS at 30 °C for 10 min
and then ultra-centrifuged at 100,000g to collect the LUVs. After a
wash with PBS, the precipitated materials were analyzed by SDS–PAGE
and immunoblotting.2.8. GST-pulldown assay
GST-pulldown assays using GST-KIAA0725p and GST-PA-PLA1,
and their mutants with FLAG-tagged constructs in 293T cells were
carried out as described previously [6].
Fig. 1. KIAA0725p and p125 are novel PIP-binding proteins.A, GST (negative control),
GST-KIAA0725p and GST-KIAA0725p S351A expressed in and puriﬁed from Sf9 cells
were incubated overnight at 4 °C with PIP strips (Echelon Bioscience). The binding of
the proteins to spotted lipids was detected using an anti-GST antibody. LPC and S1P de-
note lysophosphatidylcholine and sphingosine 1-phosphate, respectively. B, GST-PA-
PLA1 and GST-p125 were expressed and puriﬁed, and their lipid binding activity was
examined as described in A. C, puriﬁed GST (top), GST-KIAA0725p S351A (middle),
and the GST-phospholipase Cδ1 PH domain (bottom) were incubated for 10 min at
30 °C with LUVs containing no PIP (lanes 1 and 2), PI(4)P (lanes 3 and 4), or PI(4,5)
P2 (lanes 5 and 6), and then the binding was detected by immunoblotting using an
anti-GST antibody.
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P-labeled 1,2-dioleoyl-sn-phosphatidic acid (DOPA)
1,2-Dioleoyl-sn-glycerol (Sigma-Aldrich) was phosphorylated
with diacylglycerol kinase (Sigma-Aldrich) and [γ-
32
P] ATP (6000 Ci/
mmol; MP Biomedicals, Solon, OH) in DGK buffer (0.36% Triton
X-100, 20 mM imidazole, pH7.5, 20 mM NaCl, 5 mM MgCl2, 0.4 mM
EGTA, and 0.7 mM DTT) for 15 min at 37 °C. The product, DOPA, was
extracted with CHCl3/methanol/1 N HCl (67:33:100), and followed
by with CHCl3/methanol (2:1). The organic phase was recovered,
evaporated under a nitrogen gas ﬂow, dissolved in CHCl3, and then
separated by thin-layer chromatography (TLC) on a Silica gel 60 TLC
plate (EMD-Merck, Rockland, MA) with CHCl3/methanol/acetic acid
(26:6:3) as the developing solvent. The spot corresponding to the
labeled DOPA was scraped from the TLC plate and the DOPA was
extracted with CHCl3/methanol/water (16:32:13). The extract was
mixed with 0.53 volumes of CHCl3/0.58 N acetic acid (1:1), and the
organic phase containing the labeled DOPA was recovered, dried
and ﬁnally dissolved in CHCl3.
2.10. PLA1 assay
GST-KIAA0725p and GST-PA-PLA1, and their mutants were
expressed in 293T cells and partially puriﬁed as described in the
“GST-pulldown assay” section except for the use of the lysis buffer
without Triton X-100 for the washing. The GST fusion proteins bound
to the beads were used directly as enzymes for the PLA1 assays. The
reactions were started by adding 100 μl of reaction buffer [50 mM
Tris–HCl, pH7.5, 100 mM KCl, 100 μM DOPA (Avanti Polar Lipids) and
4.2 nM
32
P-labeled DOPA] to the enzyme-containing tubes. A mixture
of the cold and labeled DOPAs was applied as liposomes produced by
sonication. The reactions were conducted at 37 °C for 15 min, and
stopped by adding 200 μl of 1 N HCl and 400 μl of CHCl3/methanol
(2:1). The substrate DOPA and the product 1-oleoyl-lysophosphatidic
acid (LPA) were recovered from the organic phase, dried, dissolved in
CHCl3 and then separated by TLC as described above. The radioactive
DOPA and LPA on the TLC plate were quantiﬁed with a Bioimage Ana-
lyzer FLA-9000 (Fuji-Film, Tokyo, Japan).
2.11. Others
Prediction of domain structures and coiled-coil motifs for human
iPLA1 family proteins was carried out using the ExPASy Motifscan
(http://hits.isb-sib.ch/cgi-bin/ PFSCAN) and COILS (http://www.ch.
embnet.org/software/COILS_form.html) programs.
3. Results
3.1. KIAA0725p and p125 are novel PIP-binding proteins
To obtain a clue as to the mechanism by which KIAA0725p is tar-
geted to Golgi/ERGIC membranes, we ﬁrst examined its lipid-binding
properties. Puriﬁed GST or GST-KIAA0725p was incubated with nitro-
cellulose membranes spotted with various phospholipids, and bind-
ing was detected with an anti-GST antibody. GST-KIAA0725p
speciﬁcally bound to three PIPs, i.e. PI(3)P, PI(4)P and phosphatidyli-
nositol 5-phosphate (PI(5)P) (Fig. 1A, middle panel), while negative
control GST did not bind to any lipid (left panel). The binding
afﬁnities to the PIPs were similar although binding to PI(4)P seemed
to be slightly tighter than that to the others (Supplemental Fig. S1).
These interactions are independent of its phospholipase activity be-
cause the GST-KIAA0725p S351A mutant, which has no detectable
phospholipase activity [12], bound to the phosphoinositides as well
as the KIAA0725p wild-type (WT) did (Fig. 1A, right). p125, the
other membrane-associated member, also bound to the three PIPs,
whereas cytosolic isoform PA-PLA1 did not (Fig. 1B). To conﬁrm the
PIP binding of KIAA0725p, we performed a liposome binding assay(Fig. 1C). In this experiment, we used the lipase-defective mutant to
exclude possible cleavage of lipids in the liposomes during the assay
incubation and centrifugation. For comparison, the GST-PH domain
of phospholipase C δ1 was used. The GST-KIAA0725p S351A mutant
more tightly bound to liposomes containing PI(4)P (Fig. 1C, lane 4)
compared with to control liposomes without PIP (lane 2). However,
in contrast to the results obtained with a membrane strip assay, the
GST-KIAA0725p S351A mutant also bound to PI(4,5)P2, although the
extent of the binding was much less than that of the GST-PH domain
of phospholipase C δ1 (lane 6). These different results regarding the
binding to PI(4,5)P2 in membrane strip and liposome binding assays
may be ascribable to different states of PI(4,5)P2 in nitrocellulose
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binds to PIPs including PI(3)P, PI(4)P, PI(5)P and possibly PI(4,5)P2.
3.2. The SAM-DDHD domain is the element responsible for PIP binding
of KIAA0725p
As KIAA0725p does not have any well-known phosphoinositide-
binding domain such as a PH domain, we attempted to determine
the minimal domain(s) of KIAA0725p for binding to phosphoinosi-
tides. Given that the WWE and SAM domains are present in
membrane-associated forms (p125 and KIAA0725), but absent in a cy-
tosolic species (PA-PLA1) (Fig. 2A), these domains are candidates for a
novel PIP-binding domain. We ﬁrst constructed four mutants (Fig. 2B)
and performed a PI(4)P-binding assay using nitrocellulose strips. The
C-terminal half comprising the SAM and DDHD domains (GST-SAM-
DDHD) bound to PI(4)P (Fig. 2C, top right panel) as or more strongly
than the full-length KIAA0725p WT (middle left panel), while the
DDHD domain (GST-DDHD) (middle right panel), the SAM domain
(GST-SAM) (bottom right panel), and the N-terminal half containing
the WWE domain (GST-WWE-Lipase) (bottom left panel) exhibited
no binding activity. These results suggest that the tandem
SAM-DDHD domain is a minimal region for PIP-binding.
The PH domains of OSBP and FAPP can themselves be targeted
speciﬁcally to the trans-Golgi network [21,22]. Thus, we examined
whether or not the SAM-DDHD domain could itself be localized in
the Golgi/ERGIC. Immunoﬂuorescence microscopy showed that the
SAM-DDHD domain of KIAA0725p tagged with GST was not in the
Golgi/ERGIC, but diffusely spread over the cytoplasm (SupplementalFig. 2. The SAM-DDHD domain of KIAA0725p is a novel PIP-binding domain.A, sche-
matic representation of the domain structure of iPLA1 family proteins. The number at
the upper right indicates the number of amino acid residues in each protein. B, sche-
matic representation of KIAA0725p deletion mutants. C, PI(4)P and PC were spotted
onto nitrocellulose membranes in the indicated amounts, and then the membranes
were incubated with GST, GST-KIAA0725p WT or the deletion mutants expressed in
293T cells as described under “Experimental procedures.” The binding of the proteins
to lipids was detected as described for Fig. 1A.Fig. S2, top right panels), as for other deletion mutants, suggesting
that the SAM-DDHD domain itself does not operate as a Golgi/
ERGIC-targeting module.
3.3. A positively charged cluster in the SAM domain is required for the
PIP binding and targeting of KIAA0725p to the Golgi/ERGIC
Negatively charged PIPs interact with a cluster of positively
charged residues in typical PIP-binding proteins [23,24]. Since a pos-
itively charged Arg-434/Lys-435/Lys-436 cluster is present in the
SAM domain of KIAA0725p, we substituted each of the residues
with alanines (3RKA). The 3RKA mutant exhibited no PI(4)P-binding
activity (Fig. 3A, bottom panel) and was not localized in Golgi/ERGIC
membranes (Fig. 3B, lower row). The mislocalization of the mutant
was not due to a gross conformational change induced by the muta-
tion because its PLA1 activity was comparable to or higher than that
of the KIAA0725p WT (Fig. 5B). These results suggest that the R434/
K435/K436 cluster of KIAA0725p is important for both PI(4)P-binding
and membrane targeting.
3.4. Overexpression of KIAA0725p causes enlargement of the ERGIC in the
perinuclear region
We previously reported that overexpression of KIAA0725p caused
the dispersion of the Golgi visualized with β-COP and p115 staining,
and the aggregation of the ER visualized with calnexin staining [12].
Here we examined the distribution of an ERGIC marker, ERGIC-53,
in cells overexpressing the WT and mutants of KIAA0725p. As
reported previously [25], ERGIC-53-positive punctate structures
were found to be accumulated in the perinuclear region, with some
at the periphery of the cells (Fig. 3C). Overexpression of KIAA0725p
WT caused enlargement or aggregation of the perinuclear ERGIC con-
comitantly with a decrease or disappearance of the peripheral ERGIC
puncta (Fig. 3C, top row). Peripheral ERGIC puncta, if any remained,
were also enlarged. These effects were also observed in cells expres-
sing the KIAA0725p S351A mutant (middle row). In contrast, the
3RKA mutant, which cannot be targeted to the Golgi/ERGIC, had no
effect on the ERGIC morphology (bottom row). Quantitation showed
that more than 50% of the cells expressing the KIAA0725p WT and
KIAA0725p S351A mutant exhibited an aggregated ERGIC pattern,
while essentially no such pattern was observed for cells expressing
the 3RKA mutant (Fig. 3D).
3.5. Sac1 phosphoinositide phosphatase regulates KIAA0725p
localization
PI(4)P is abundant in the Golgi and ER exit sites, and plays impor-
tant roles in membrane trafﬁcking events, including the recruitment
of coat proteins and cargo sorting [26–28]. To conﬁrm that PIP is
important for the association of KIAA0725p with Golgi/ERGIC mem-
branes, we manipulated the PIP levels in Golgi/ERGIC by using Sac1.
Sac1 is a phosphoinositide phosphatase that prefers PI(3)P and
PI(4)P, and is predominantly localized in the ER and Golgi under
nutrient-rich and starvation conditions, respectively [27]. When
WT Sac1 was expressed, the population of expressed KIAA0725p
colocalized with the perinuclear ERGIC (perinuclear aggregation)
was slightly decreased (Fig. 4A, second row, and quantitation in
B). Because Sac1 is cycled between the ER and Golgi, some fraction
of the expressed Sac1, as a consequence of overexpression, may be
localized in ERGIC/Golgi membranes, leading to the dissociation of
expressed KIAA0725p from aggregated ERGIC membranes. The
expression of the Sac1 K2A mutant, which is deﬁcient in the ER re-
trieval signal and considerably remains in the Golgi, caused drastic
redistribution of KIAA0725p from both the Golgi and the perinuc-
lear aggregates to the cytoplasmic punctate structures (Fig. 4A,
third row, and B). These effects were not observed with the
Fig. 3. A positively charged cluster in the SAM-DDHD domain is necessary for the targeting of KIAA0725p to the Golgi/ERGIC.A, GST (top panel), GST-KIAA0725pWT (middle panel),
and the 3RKA mutant (bottom panel) expressed in 293T cells were incubated with PI(4)P- and PC-spotted nitrocellulose membranes, and then the binding was detected with an
anti-GST antibody as described in Fig. 2C. B, the expression plasmid for FLAG-tagged KIAA0725p WT or the 3RKA mutant was transiently transfected into HeLa cells. After 18 h, the
expressed proteins and GM130, a Golgi marker, were visualized with antibodies to a FLAG tag and GM130, respectively, followed by appropriate ﬂuorophore-conjugated secondary
antibodies. C, FLAG-tagged KIAA0725p WT (top row), S351A (middle row), or the 3RKA mutant (bottom row) was transiently expressed in HeLa cells, and then visualized together
with ERGIC-53 as described in B. D, quantitative analysis of the ERGIC aggregation induced by overexpression of KIAA0725p WT, S351A and 3RKA mutants. In the experiments
shown in C, the ratios of the cells with aggregated ERGIC among the KIAA0725p WT or mutant-transfected cells were calculated and expressed as means±S.E. The experiments
were repeated 4 times, and at least 100 cells were counted in each experiment. The asterisks indicate statistically signiﬁcant differences; *Pb0.05; **Pb0.01, with Student's t-
test in comparison with empty vector-transfected cells.
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B). These results suggest that the levels of phosphoinositides in-
cluding PI(4)P regulate the recruitment of KIAA0725p to the
Golgi/ERGIC.
3.6. The DDHD domain of KIAA0725p and PA-PLA1 is essential for
PLA1 activity
The DDHD domain is a ~250-amino acids stretch found in iPLA1
family proteins and some phosphatidylinositol transfer proteins
[15–17]. The function of this domain remains unknown. To under-
stand the role of the DDHD domain in the context of PLA1 activity,
we ﬁrst constructed a series of deletion mutants of KIAA0725p
and PA-PLA1 (Fig. 5A), and measured their PLA1 activities. In
terms of KIAA0725p, neither of the deletion mutants showed PLA1
activity (Fig. 5B). In the case of PA-PLA1, on the other hand, thedeletion mutant 142-DDHD and 348-DDHD, which lack the N-
terminal 141 and 347 amino acids, respectively, exhibited a less
but substantial activity compared with the WT enzyme (Fig. 5C).
Deletion of the C-terminal 235 amino acids (Gly-CC) or 25 amino
acids (Gly-847) severely abrogated the activity (Fig. 5C). It should
be noted that the latter construct lacks only the C-terminal 11
amino acids of the DDHD domain, suggesting the importance of
the DDHD domain for PLA1 activity. The DDHD domain is named
after four conserved residues, three aspartates and one histidine.
To evaluate the signiﬁcance of these residues in PLA1 activity,
these residues (Asp-662, Asp-820, His-839 and Asp-847) were indi-
vidually substituted with an alanine. Of the four substitutions, those
of two aspartates and the histidine (Asp-662, Asp-820 and His-839)
markedly abolished the PLA1 activity (Fig. 5D). These results sug-
gest that the integrity of the DDHD domain is necessary for the
PLA1 enzymatic activity.
Fig. 4. Sac1 phosphatase reduces the perinuclear accumulation of KIAA0725p-positive vesicles.A, FLAG-tagged KIAA0725pWTwas transiently expressed in HeLa cells together with
GFP-tagged Sac1 WT, ER-retention signal defective mutant K2A or phosphatase activity-negative mutant C/S. After 18 h, the cells were ﬁxed, stained, and analyzed by confocal mi-
croscopy. Enlarged images are shown in insets. B, quantitative analysis of the effect of Sac1 expression on KIAA0725p localization. In the experiments shown in A, the ratios of the
cells with the indicated localization of KIAA0725p among the GFP-positive cells were calculated and expressed as means±S.E. The experiments were repeated 4 times, and at least
100 cells were counted in each experiment. The asterisks indicate statistically signiﬁcant differences; **Pb0.01, with Student's t-test in comparison with GFP-transfected cells in
each data set.
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terminal half and DDHD domain
PA-PLA1 forms homooligomers, probably homotetramers [4]. We
examined whether or not KIAA0725p also forms homooligomers
and, if so, whether or not it also forms heterooligomers with PA-
PLA1. GST-tagged PA-PLA1 or KIAA0725p was expressed with FLAG-
tagged versions in 293T cells, and their interactions were analyzed
by GST pulldown assays and immunoblotting. As shown in Fig. 6A,
both PA-PLA1 and KIAA0725p preferentially formed homooligomers
(lanes 4 and 9, top panel), although small amounts of heterooligo-
mers were also formed (lanes 6 and 7, top panel).
To determine which region(s) are responsible for the oligomer for-
mation,weﬁrstmutated the coiled-coil region,which is present between
the lipase motif and the DDHD domain of PA-PLA1 (Fig. 5A). We con-
structed two mutants in which the coiled-coil structure was destroyed
by a deletion or point mutations. The COILS program predicted complete
abrogation of the coiled-coil structure of the two mutants (data not
shown). GST pulldown assaying showed that both mutants formed
homooligomers comparable with WT PA-PLA1 (Fig. 6B, lanes 3 and 4,
top panel), suggesting that the coiled-coil domain is not necessary for
oligomer formation by PA-PLA1. We then used a series of deletion mu-
tants (Figs. 2A and 5A). Unexpectedly, each of the tested deletion mu-
tants except for the SAM domain construct of KIAA0725p and the Gly-
rich domain construct of PA-PLA1 interacted with its own full-length
form (Fig. 6C, top panel). These results suggest that multiple sites are in-
volved in the oligomer formation. To test this possibility, we examined
whether or not the DDHD domain of KIAA0725p (Fig. 2B) binds to theN-terminal half of the molecule lacking the DDHD domain (WWE-
SAM; Fig. 5A). A GST pulldown assay demonstrated that the DDHD do-
main more strongly associates with the WWE-SAM construct than with
the full-length form (Fig. 6D, lane 3, top panel). In contrast, no binding
between the DDHD domainswas observed (lane 4, top panel). The inter-
action between theWWE-SAMand theDDHDdomainwas notmodulat-
ed by PI(4)P (Fig. 6E). These results suggest that KIAA0725p forms
oligomers through multiple interactions between different regions, in-
cluding an interaction between the DDHD domain and the N-terminal
half of the molecule in a PI(4)P-independent manner.
4. Discussion
In this study, we showed that KIAA0725p is a novel
phosphoinositide-binding protein. Deletion and point mutation ana-
lyses demonstrated that the minimal region for the binding is a unique
tandem SAM-DDHD domain. The R434/K435/K436 positively charged
cluster in the SAM domain is critical for both PIP binding and targeting
of KIAA0725p to the Golgi/ERGIC, but neither for its PLA1 activity nor its
homooligomer formation. On the other hand, the DDHD domain is
essential for its enzymatic activity and oligomer formation.
Speciﬁc phosphoinositides are accumulated in particular organ-
elle membranes, and modulate membrane sorting and deformation
machineries [1,2]. PI(4)P is present in the ER and Golgi apparatus.
Recent studies suggested that PI(4)P plays an important role in
membrane trafﬁcking from the ER to the Golgi [26,29,30]. Our in
vitro lipid overlay and liposome sedimentation assays showed that
KIAA0725p interacts with three PIPs, i.e. PI(3)P, PI(4)P and PI(5)P,
Fig. 5. The DDHD domain and conserved residues D, D and H are important for PLA1 activity.A, schematic representation of the deletion mutants of KIAA0725p and PA-PLA1 used for
PLA1 assaying. The DDHD domain of PA-PLA1 encompasses amino acids 611–858. The Gly-847 mutant lacks the C-terminal 11 amino acids of the DDHD domain. GST-tagged
KIAA0725p deletion mutants (B), PA-PLA1 deletion mutants (C), or PA-PLA1 point mutants (D) were expressed in 293T cells and partially puriﬁed, and then their PLA1 activities
were measured using
32
P-labeled DOPA as a substrate. The asterisks indicate statistically signiﬁcant differences; *Pb0.05; **Pb0.01, with Student's t-test in comparison with WT.
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Fig. 6. KIAAA0725p forms homooligomers through interaction between the DDHD domain and the N-terminal half of the molecule.A, the expression vector encoding GST, GST-PA-
PLA1 or KIAA0725p was transfected in 293T cells together with the vector for FLAG-PA-PLA1, p125 or KIAA0725p. 18 h after transfection, the cells were harvested and lysed, and
GST-tagged proteins were pulled down (PD) using glutathione beads. The precipitated materials were analyzed by immunoblotting with an anti-FLAG antibody (top panel). 2%
input was also analyzed by immunoblotting with antibodies to FLAG (middle panel) and GST (bottom panel). B, GST, GST-PA-PLA1 or GST-PA-PLA1 mutants with deletion or
point mutations in the coiled-coil region were transiently expressed together with FLAG-PA-PLA1 WT in 293T cells, and then GST pulldown experiments were performed as de-
scribed in A. C, GST-tagged deletion mutants of KIAA0725p or PA-PLA1, shown in Figs. 2B and 5A, and the Gly-rich domain construct (amino acids 1–176) of PA-PLA1 were tran-
siently expressed in 293T cells together with their WT FLAG-tagged constructs, and then GST pulldown assays were performed as described in A. D, GST, GST-KIAA0725p, or the
WWE-SAM or DDHD construct was transiently expressed together with FLAG-DDHD in 293T cells, and then GST pulldown experiments were performed as described in A. E,
GST pulldown experiments were conducted as described in D in the presence of the indicated concentrations of PI(4)P.
937H. Inoue et al. / Biochimica et Biophysica Acta 1823 (2012) 930–939with similar afﬁnities. As KIAA0725p was found to be associated
with the Golgi/ERGIC, it is tempting to speculate that a primary tar-
get of KIAA0725p is PI(4)P. However, it should be noted that the af-
ﬁnities of KIAA0725 for PIPs may not be high enough to target it to
membranes in vivo. The tandem SAM-DDHD domain, which isresponsible for PIP binding, failed to be targeted to the Golgi/
ERGIC. In addition to PI(4)P, KIAA0725p may require proteins resid-
ing in the Golgi/ERGIC for its association with membranes. Alterna-
tively, oligomerization may contribute to stable binding of
KIAA0725 to target membranes.
Fig. 7. Alignment of SAM domains.Positively charged residues and the residues of EphB2 involved in hydrophobic interactions for oligomer formation are underlined and double-
underlined, respectively. Hatched bars indicate the ﬁve α-helices in the SAM domain. h, human; y, yeast; d, Drosophila.
938 H. Inoue et al. / Biochimica et Biophysica Acta 1823 (2012) 930–939The SAM domain is a widespread motif in signaling and nuclear pro-
teins. SAMdomains are among themost abundant protein–protein inter-
actionmotifs, including in protein oligomerization and RNA binding [31].
Some studies suggested that SAM domains also interact with lipids
[32–34], but the physiological signiﬁcance of this remains unknown. In
the present study, we demonstrated that the SAM domain of KIAA0725
constitutes a part of the PIP binding site. This ﬁnding is consistent with
that both KIAA0725 and p125 bind to PIPs, whereas PA-PLA1 does not.
The former two homologues contain a SAM domain, whereas the latter
has a coiled-coil region instead of a SAM domain (Fig. 2A).
Fig. 7 shows alignment of the SAM domains involved in PIP
binding (human KIAA0725p and p125), RNA binding (yeast VTS1
and Drosophila Smaug), and oligomer formation (human EphB2).
R434/K435/K436, mutations of which abolish membrane targeting,
are located in the N-terminus of helix α5. This positively charged
cluster is well conserved and constitutes a part of the RNA-binding
site in yeast VTS1 and Drosophila Smaug. The other RNA binding mo-
tifs in these proteins are a positively charged cluster located in a re-
gion encompassing the C-terminus of helix α1, the ensuing loop,
and most of helix α2 [35–39]. iPLA1 family members lack positively
charged residues in helix α2 and the preceding loop. It is possible
that one positively charged cluster may be enough for binding to
PIPs. Although a conserved positively charged cluster at the
C-terminus of the SAM domains is present in iPLA1 family members,
the amino acid residues responsible for oligomer formation between
the SAM domains are not conserved. The hydrophobic residues
found in EphB2 (Fig. 7, double-underline), which are involved in
two types of interactions for oligomer formation [40,41], are replaced
by hydrophilic or charged residues in iPLA1 family members. This may
explain the lack of ability of the SAM domain of KIAA0725p to
mediate protein–protein interactions (Fig. 6C).
The DDHD domain is conserved in iPLA1 family proteins and some
phosphatidylinositol transfer proteins [15–17]. We assumed that this
domain of iPLA1 family proteins participates in their phospholipase
activity. Our mutational analysis demonstrated this assumption to
be correct; substitutions of the three conserved residues in the
DDHD domain severely impaired the PLA1 activity of PA-PLA1. In
addition, our study showed that this domain plays two more roles:
in PIP binding and oligomerization. To exhibit phospholipase activity,
almost the full-length KIAA0725p protein, which encompasses from
the N-terminal WWE domain to the C-terminal DDHD domain, is
necessary. As WWE domains mediate protein–protein interactions
in general [42], this domain in KIAA0725p may contribute to the
expression of PLA1 activity through an interaction with the
C-terminal DDHD domain or any other domains. While the ExPASy
Motifscan program does not predict the existence of a WWE domain
in the N-terminal region of PA-PLA1 because of a short insertion, a
typical sequence for a WWE domain [W-(bulky)-(hydrophobic)-
X(5–10)-W/F/Y-X-X-W/F/Y-X(5–16)-(aliphatic)-E/D/Q/R] appears
to be present in a region following the Gly-rich domain. Since the mu-
tant 348-DDHD, which lacks this region, exhibited a PLA1 activity
comparable to that of the mutant 142-DDHD, this WWE-like domain
may not function. Alternatively, this WWE-like domain and a coiled-coil region located on the N-terminal side of the DDHD domain, both
of which are unique in PA-PLA1, may be involved in the regulation of
this enzymatic activity by PI [43].
In conclusion, we have demonstrated a novel mechanism by
which KIAA0725p is targeted to the Golgi/ERGIC. KIAA0725p binds
to phosphoinositides through a positively charged cluster in the
SAM domain. The DDHD domain in PLA1 family proteins is a multi-
functional domain for PI(4)P binding, oligomer formation and enzy-
matic activity.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamcr.2012.02.002.
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